Cenna Biosciences
About:
Cenna Biosciences develops disease modifying drugs for Alzheimer's disease using a proprietary novel mechanism.
Website: http://www.cennabiosciences.com/index.html?key=8953
Top Investors: National Institutes of Health, National Institute on Aging
Description:
Total Funding Amount:
$2.7M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
La Jolla, California, United States
Founded Date:
2006-01-01
Contact Email:
info(AT)cennabiosciences.com
Founders:
Jonathan Singer, Nazneen Dewji
Number of Employees:
1-10
Last Funding Date:
2024-09-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai